Načítá se...
LCZ696 ameliorates lipopolysaccharide-induced endothelial injury
Lipopolysaccharide (LPS)-induced endothelial dysfunction plays an important role in the pathogenesis of cardiovascular diseases. LCZ696, the dual-acting angiotensin receptor blocker, and neprilysin inhibitor has been used for the treatment of heart failure with reduced ejection fraction. Recent work...
Uloženo v:
| Vydáno v: | Aging (Albany NY) |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Impact Journals
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8064163/ https://ncbi.nlm.nih.gov/pubmed/33839697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.202692 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|